Judith Hsia

发表

Effects of Rosuvastatin and Atorvastatin on Low-Density and High-Density Lipoprotein Particle Concentrations in Patients With Metabolic Syndrome: A Randomized, Double-Blind, Controlled Study

Robert S. Rosenson, James D. Otvos, Judith Hsia, 2009 .

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.

JoAnn E Manson, Mark A Espeland, Robert Wallace, 2004, JAMA.

Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.

Jennifer G. Robinson, Mary Cushman, Charles Kooperberg, 2008, Archives of internal medicine.

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

Charles B Eaton, J. Manson, R. Langer, 2006, Archives of internal medicine.

Calcium plus vitamin D supplementation and the risk of colorectal cancer.

John Robbins, Thomas E Rohan, Lewis H Kuller, 2006, The New England journal of medicine.

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Deborah Grady, Eric Vittinghoff, Steven Khan, 2002, JAMA.

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.

JoAnn E. Manson, Robert B. Wallace, Mark A. Espeland, 2004 .

Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Lewis H Kuller, Robert B Wallace, Charles Kooperberg, 2013, JAMA.

Estrogen plus progestin and the risk of coronary heart disease.

Mary Cushman, Robert Detrano, Ora L Strickland, 2003, The New England journal of medicine.

Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model

C. Andy Schuetz, J. Hsia, A. Schuetz, 2012, Journal of medical economics.

Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

Paul M Ridker, P. Ridker, J. Hsia, 2011, Journal of the American College of Cardiology.

National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

John Robbins, Lawrence Phillips, Bette Caan, 2004, BMJ : British Medical Journal.

Predictors of Heart Failure in Patients With Stable Coronary Artery Disease: A PEACE Study

Marc A Pfeffer, Jean Rouleau, S. Solomon, 2009, Circulation. Heart failure.